UBS advice for Schott Pharma
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| July 09, 2024 | UBS | Schott Pharma | Buy | 32.60 EUR | 25.95 % |
Advice details
London - Op 09 jul (her)starten de analisten van UBS met het volgen van Schott Pharma () met een koopadvies. Het 12-maands koersdoel is vastgesteld op 32.6 EUR
Last UBS advice for Schott Pharma
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| July 09, 2024 | UBS | Schott Pharma | Buy | 32.60 EUR | 25.95 % |
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 